视网膜血氧测定:视网膜与脑部疾病的代谢成像
该综述介绍视网膜血氧测定这一无创、可重复的血管血红蛋白氧饱和度成像技术,并汇总其在糖尿病视网膜病变、视网膜中央静脉阻塞、青光眼、视网膜色素变性及全身与中枢神经系统疾病中的病理生理学原理与新型生物标志物。
要点
- 视网膜静脉血氧饱和度在糖尿病视网膜病变中升高,动静脉差随病情进展逐渐降低。
- 视网膜血氧测定可客观反映视网膜缺氧,并与视网膜中央静脉阻塞的周边缺血、视力及黄斑水肿厚度相关。
- 青光眼性视网膜萎缩与氧消耗减少相关,表现为动静脉差降低和视网膜静脉饱和度升高。
核心结论
- 视网膜血氧测定是一种无创、可重复的代谢成像技术,已在多种视网膜疾病及全身和脑部疾病中发现病理生理学原理与新型生物标志物。
研究设计与样本
- 综述,介绍视网膜血氧测定这一视网膜血管血红蛋白氧饱和度成像技术的原理与临床应用。
主要发现
- 糖尿病视网膜病变中视网膜静脉氧饱和度升高,动静脉差随视网膜病变进展逐渐降低,与缺氧刺激VEGF产生的病理生理机制相关。
- 激光治疗与玻璃体切除术均改善视网膜血氧测定值,且与临床结局相关。
- 视网膜中央静脉阻塞以视网膜缺氧为特征,血氧测定所见的视网膜缺氧与周边缺血范围、视力及黄斑水肿厚度相关。
- 青光眼性视网膜萎缩与氧消耗减少相关,表现为动静脉差降低和视网膜静脉饱和度升高,血氧测定结果与更差的视野、更薄的神经纤维层及更小的视盘沿相关。
- 视网膜色素变性的晚期萎缩与更差视野和更高的视网膜静脉氧饱和度、更低的动静脉差之间存在关联。
关键数值与推荐
- 糖尿病视网膜病变中视网膜静脉氧饱和度升高、动静脉差在晚期逐渐降低,与健康人相比。
- 视网膜中央静脉阻塞中血氧测定所见的视网膜缺氧与周边缺血范围、视力和黄斑水肿厚度相关。
- 青光眼性视网膜萎缩与动静脉差降低和视网膜静脉饱和度升高相关,并与更差视野、更薄神经纤维层和更小视盘沿相关。
- 视网膜色素变性中晚期萎缩、更差视野与更高视网膜静脉氧饱和度、更低动静脉差存在关联。
临床怎么用
- 视网膜血氧测定生物标志物可能实现糖尿病视网膜病变严重程度的自动测量并预测其治疗反应。
- 该生物标志物可能有助于诊断和测量静脉阻塞的严重程度及视网膜缺血程度。
- 该生物标志物为青光眼性损害提供客观指标。
- 该生物标志物可能用于测量视网膜色素变性及其他萎缩性视网膜疾病的严重程度和进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Retinal oximetry imaging of retinal blood vessels measures oxygen saturation of hemoglobin. The imaging technology is non-invasive and reproducible with remarkably low variability on test-retest studies and in healthy cohorts. Pathophysiological principles and novel biomarkers in several retinal diseases have been discovered, as well as possible applications for systemic and brain disease. In diabetic retinopathy, retinal venous oxygen saturation is elevated and arteriovenous difference progressively reduced in advanced stages of retinopathy compared with healthy persons. This correlates with pathophysiology of diabetic retinopathy where hypoxia stimulates VEGF production. Laser treatment and vitrectomy both improve retinal oximetry values, which correlate with clinical outcome. The oximetry biomarker may allow automatic measurement of severity of diabetic retinopathy and predict its response to treatment. Central retinal vein occlusion is characterized by retinal hypoxia, which is evident in retinal oximetry. The retinal hypoxia seen on oximetry correlates with the extent of peripheral ischemia, visual acuity and thickness of macular edema. This biomarker may help diagnose and measure severity of vein occlusion and degree of retinal ischemia. Glaucomatous retinal atrophy is associated with reduced oxygen consumption resulting in reduced arteriovenous difference and higher retinal venous saturation. The oximetry findings correlate with worse visual field, thinner nerve fiber layer and smaller optic disc rim. This provides an objective biomarker for glaucomatous damage. In retinitis pigmentosa, an association exists between advanced atrophy, worse visual field and higher retinal venous oxygen saturation, lower arteriovenous difference. This biomarker may allow measurement of severity and progression of retinitis pigmentosa and other atrophic retinal diseases. Retinal oximetry offers visible light imaging of systemic and central nervous system vessels. It senses hypoxia in cardiac and pulmonary diseases. Oximetry biomarkers have been discovered in Alzheimer's disease and multiple sclerosis and oxygen levels in the retina correspond well with brain.
引用
- Stefánsson E, Olafsdottir OB, Eliasdottir TS, et al. Retinal oximetry: Metabolic imaging for diseases of the retina and brain. Prog Retin Eye Res. 2019. PMID: 30999027. doi:10.1016/j.preteyeres.2019.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。